logo

For the Inventor, By the Inventor

Abano Terme, Italy

Fidia Farmaceutici S.p.a.


USPTO Granted Patents = 88

% Expired Patents = 17.0



Trademarks = 35

Forward Citations = 286

Loading Chart...
Loading Chart...

103 inventors (with patents filed for the assignee):

goldMedal Giovanni Gennari (20 out of 21 patents)

silverMedal Susanna Vaccaro (16 out of 17 patents)

bronzeMedal Anna Maria Zanellato (15 out of 15 patents)

4.  Lanfranco Callegaro (11 out of 60 patents)

5.  Davide Renier (10 out of 13 patents)

6.  Vincenza Corsa (9 out of 9 patents)

7.  Luciano Messina (9 out of 9 patents)

8.  Devis Galesso (8 out of 8 patents)

9.  Monica Campisi (8 out of 8 patents)

10.  Davide Bellini (7 out of 15 patents)

11.  Matteo D'Este (6 out of 6 patents)

12.  Carlo Pizzocaro (6 out of 6 patents)

13.  Salvatore Caruso (4 out of 4 patents)

14.  Cristian Guarise (4 out of 4 patents)

15.  Alessandro Negro (4 out of 6 patents)


Core Competencies:
Hyaluronic Acid
Controlled Release
Wound Healing
Bioconjugates
Pharmaceutical Compositions
Antitumoral Drugs
Sulfated Hyaluronic Acid
Dermal Therapeutics
Bio-inks
Compositions with Antibacterial Activity
Viscoelastic Gels
Microemulsions

88 patents:

1. 12721862 - Pharmaceutical composition for use in the treatment of cystitis of various etiologies (2026-09-01),
2. 12691139 - Antiviral agents for prevention or treatment of pathologies caused by alpha- and/or beta-coronaviruses (2026-07-28),
3. 12605355 - HA-paclitaxel conjugate for treatment of mesothelioma (2026-04-21),
4. 12465649 - Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer (2025-11-11),
5. 12465596 - Stabilisation and controlled-release systems for medicaments unstable on sterilisation (2025-11-11),
6. 12447134 - Multilayer composite material (2025-10-21),
7. 12403646 - Method for 3D printing with a bio-ink (2025-09-02),
8. 12364784 - Wound dressing for treatment of damaged skin (2025-07-22),
9. 12310942 - Pharmaceutical compositions comprising statins and hyaluronic acid derivatives (2025-05-27),
10. 12251416 - Pharmaceutical compositions containing hyaluronic acid and carnosine and relative use (2025-03-18),
11. 12135262 - Comminuting device of biological material and relative method for comminuting and cellular preparations (2024-11-05),
12. 12115229 - Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes (2024-10-15),
13. 11684588 - Multilayer composite material (2023-06-27),
14. 11613743 - Process for the production and purification of the collagenase enzyme from (2023-03-28),
15. 11510995 - Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes (2022-11-29),
Fidia Farmaceutici S.p.a., headquartered in Abano Terme, Italy, specializes in the development and manufacturing of innovative pharmaceutical products, particularly focusing on hyaluronic acid derivatives. The company is recognized for its advancements in controlled release formulations and bioconjugates, which are pivotal in wound healing and dermal therapeutics. Fidia's research extends to antitumoral drugs and sulfated hyaluronic acid, positioning it as a key player in the pharmaceutical landscape, dedicated to enhancing patient care through cutting-edge technology.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Fidia Farmaceutici S.p.a.
88 Patents

#2 in Abano Terme

#111 in Italy

#8,678 in the World

Abano Terme, IT
Abano Terme, Italy

Fidia Farmaceutici S.p.a.

Forward Citations = 286

103 inventors:

goldMedal Giovanni Gennari (20 out of 21 patents)

silverMedal Susanna Vaccaro (16 out of 17 patents)

bronzeMedal Anna Maria Zanellato (15 out of 15 patents)

4.  Lanfranco Callegaro (11 out of 60 patents)

5.  Davide Renier (10 out of 13 patents)

Please report any incorrect information to [email protected]
Loading…